COBAS 6000 C501 MODULE 05036453001

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2010-10-12 for COBAS 6000 C501 MODULE 05036453001 manufactured by Roche Diagnostics.

Event Text Entries

[1770571] A customer received questionable results for multiple assays when testing four patient samples. Results for three of the patients were discrepant. Patient 1, newborn: the initial glucose result was 7 mg/dl. The sample repeated on a different analyzer (serial number unknown) gave 135 mg/dl. The initial alkaline phosphatase result was 6 u/l. The sample repeated on a different analyzer (serial number unknown) gave 57 u/l. The initial total protein result was 0. 4 g/dl. The sample repeated on a different analyzer (serial number unknown) gave 6. 6 g/dl. Patient 2, female newborn: the initial co2 result was 19 mmol/l. The sample repeated on a different analyzer (serial number unknown) gave 28 mmol/l. The initial total protein result was 1. 4 g/dl. The sample repeated on a different analyzer (serial number unknown) gave 4. 1 g/dl. The initial glucose result was 44 mg/dl. The sample repeated on a different analyzer (serial number unknown) gave 71 mg/dl. The initial total bilirubin result was 2. 1 mg/dl. The sample repeated on a different analyzer (serial number unknown) gave 7. 2 mg/dl. The initial alkaline phosphatase result was 200 u/l. The sample repeated on a different analyzer (serial number unknown) gave 571 u/l. The initial phosphorus result was 1. 5 mg/dl. The sample repeated on a different analyzer (serial number unknown) gave 4. 7 mg/dl. Patient 3, male newborn: the initial total bilirubin result was 0. 2 mg/dl. The sample repeated on the same analyzer gave 8. 8 mg/dl. The only initial results reported outside the laboratory were the total bilirubin results for patient 3. The customer had not been informed of any treatment provided, altered or withheld due to the initial results. No adverse events were reported. Reagent lot numbers: co2 628042 total protein 631380 glucose 625902 total bilirubin 62872801 alkaline phosphatase 62762601 phosphorus 627979 the field service representative was unable to reproduce the erroneous results or determine a cause. He inspected instrument sampling and cuvette rinse functions as a preventive measure. The customer ran precision and quality control on all tests involved and the results were within specification.
Patient Sequence No: 1, Text Type: D, B5


[8709621] .
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2010-06064
MDR Report Key1864575
Report Source05,06
Date Received2010-10-12
Date of Report2010-10-12
Date of Event2010-09-20
Date Mfgr Received2010-09-20
Date Added to Maude2010-11-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location3
Manufacturer ContactNA ERIC KOLODZIEJ
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175212834
Manufacturer G1HITACHI HIGH TECH CORP.
Manufacturer Street882 ICHIGE HITACHINAKA NA
Manufacturer CityIBARAKI 312-8504
Manufacturer Postal Code312-8504
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameCOBAS 6000 C501 MODULE
Generic NameCLINICAL CHEMISTRY ANALYZER
Product CodeCEK
Date Received2010-10-12
Model NumberNA
Catalog Number05036453001
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2010-10-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.